Literature DB >> 15288821

Pathogenesis of filoviral haemorrhagic fevers.

Siddhartha Mahanty1, Mike Bray.   

Abstract

The filoviruses, marburgvirus and ebolavirus, cause epidemics of haemorrhagic fever with high case-fatality rates. The severe illness results from a complex of pathogenetic mechanisms that enable the virus to suppress innate and adaptive immune responses, infect and kill a broad variety of cell types, and elicit strong inflammatory responses and disseminated intravascular coagulation, producing a syndrome resembling septic shock. Most experimental data have been obtained on Zaire ebolavirus, which causes uniformly lethal disease in experimentally infected non-human primates but produces a broader range of outcomes in naturally infected human beings. 10-30% of patients can survive the illness by mobilising adaptive immune responses, and there is limited evidence that mild or symptomless infections also occur. The other filoviruses that have caused human disease, Sudan ebolavirus, Ivory Coast ebolavirus, and marburgvirus, produce a similar illness but with somewhat lower case-fatality rates. Variations in outcome during an epidemic might be due partly to genetically determined differences in innate immune responses to the viruses. Recent studies in non-human primates have shown that blocking of certain host responses, such as the coagulation cascade, can result in reduced viral replication and improved host survival.

Entities:  

Mesh:

Year:  2004        PMID: 15288821     DOI: 10.1016/S1473-3099(04)01103-X

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  103 in total

Review 1.  Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling.

Authors:  Gavin C Bowick; Alexander J McAuley
Journal:  Bioeng Bugs       Date:  2011-05-01

2.  Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus.

Authors:  Hideki Ebihara; Barry Rockx; Andrea Marzi; Friederike Feldmann; Elaine Haddock; Douglas Brining; Rachel A LaCasse; Don Gardner; Heinz Feldmann
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

3.  Robust and sustained immune activation in human Ebola virus infection.

Authors:  Judith N Mandl; Mark B Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-07       Impact factor: 11.205

4.  Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice.

Authors:  Wenfang Li; Ling Ye; Ricardo Carrion; Gopi S Mohan; Jerritt Nunneley; Hilary Staples; Anysha Ticer; Jean L Patterson; Richard W Compans; Chinglai Yang
Journal:  J Infect Dis       Date:  2015-04-14       Impact factor: 5.226

5.  Ebolavirus VP35 interacts with the cytoplasmic dynein light chain 8.

Authors:  Toru Kubota; Mayumi Matsuoka; Tsung-Hsien Chang; Mike Bray; Steven Jones; Masato Tashiro; Atsushi Kato; Keiko Ozato
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

Review 6.  Immune defence, parasite evasion strategies and their relevance for 'macroscopic phenomena' such as virulence.

Authors:  Paul Schmid-Hempel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-12       Impact factor: 6.237

7.  Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain.

Authors:  Michael Schümann; Thorsten Gantke; Elke Mühlberger
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

8.  Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.

Authors:  St Patrick Reid; Charalampos Valmas; Osvaldo Martinez; Freddy Mauricio Sanchez; Christopher F Basler
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

9.  RNA Binding of Ebola Virus VP30 Is Essential for Activating Viral Transcription.

Authors:  Nadine Biedenkopf; Julia Schlereth; Arnold Grünweller; Stephan Becker; Roland K Hartmann
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

10.  Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition.

Authors:  Osvaldo Martinez; Joshua Johnson; Balaji Manicassamy; Lijun Rong; Gene G Olinger; Lisa E Hensley; Christopher F Basler
Journal:  Cell Microbiol       Date:  2009-09-22       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.